Clinical trial

NAD Augmentation in Diabetes Kidney Disease

NCT05759468

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-04-13

PhasePHASE2

Study timeline

Study start (actual)2023-04-13Date precision: day

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2diabetesunresolved

Diabetic Kidney Diseaseunresolved

Interventions

Investigational Product - MIB 626DRUG

PlaceboDRUG

Sponsors & collaborators

Brigham and Women's Hospitallead sponsor

Boston Medical Centercollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05759468 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.